← FDA Drug Approvals (Drugs@FDA)

CYCLOPHOSPHAMIDE

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2023-06-27

Drug application

FDA Application #

NDA217651

Application type

New Drug Application

Brand name

CYCLOPHOSPHAMIDE

Generic name

CYCLOPHOSPHAMIDE INJECTION, SOLUTION

Active ingredients

CYCLOPHOSPHAMIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Company

First approval

2023-06-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown